Hossein Saleki

2.2k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

Hossein Saleki is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hossein Saleki has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hossein Saleki's work include Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Hossein Saleki is often cited by papers focused on Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Hossein Saleki collaborates with scholars based in Iran, Türkiye and Singapore. Hossein Saleki's co-authors include Amirhossein Zabolian, Ali Zarrabi, Milad Ashrafizadeh, Kiavash Hushmandi, Alan Prem Kumar, Sepideh Mirzaei, Seyed Omid Sharifzadeh, Gautam Sethi, Haroon Khan and Farid Hashemi and has published in prestigious journals such as International Journal of Molecular Sciences, Carbohydrate Polymers and Molecules.

In The Last Decade

Hossein Saleki

19 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling

2022 393 citations Mahshid Deldar Abad Paskeh, Maliheh Entezari et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hossein Saleki Iran	17	1.1k	598	191	179	148	19	1.6k
Mohsen Rashidi Iran	24	996 0.9×	488 0.8×	320 1.7×	166 0.9×	174 1.2×	96	1.9k
Qiuyan Guo China	26	961 0.9×	334 0.6×	154 0.8×	208 1.2×	144 1.0×	83	1.8k
Amir R. Afshari Iran	25	753 0.7×	249 0.4×	219 1.1×	158 0.9×	166 1.1×	76	1.7k
Cristina P. R. Xavier Portugal	20	1.2k 1.1×	509 0.9×	443 2.3×	246 1.4×	137 0.9×	46	1.9k
Kai Jiang China	20	999 0.9×	440 0.7×	300 1.6×	290 1.6×	194 1.3×	67	1.8k
Sadaf Davudian Iran	6	1.0k 1.0×	396 0.7×	419 2.2×	192 1.1×	174 1.2×	8	1.7k
Elif Damla Arısan Türkiye	23	756 0.7×	332 0.6×	229 1.2×	90 0.5×	83 0.6×	91	1.4k
Haiyang Yu China	23	867 0.8×	327 0.5×	210 1.1×	166 0.9×	110 0.7×	92	1.9k
Amareshwar T.K. Singh United States	17	1.2k 1.2×	368 0.6×	458 2.4×	150 0.8×	186 1.3×	32	2.3k

Countries citing papers authored by Hossein Saleki

Since Specialization

Citations

This map shows the geographic impact of Hossein Saleki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossein Saleki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossein Saleki more than expected).

Fields of papers citing papers by Hossein Saleki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hossein Saleki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossein Saleki. The network helps show where Hossein Saleki may publish in the future.

Co-authorship network of co-authors of Hossein Saleki

This figure shows the co-authorship network connecting the top 25 collaborators of Hossein Saleki. A scholar is included among the top collaborators of Hossein Saleki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hossein Saleki. Hossein Saleki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zarrabi, Ali, Anupam Bishayee, Sepideh Mirzaei, et al.. (2022). Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A NovelTherapeutic Strategy. Current Molecular Pharmacology. 16(3). 280–306. 20 indexed citations

Paskeh, Mahshid Deldar Abad, Maliheh Entezari, Sepideh Mirzaei, et al.. (2022). Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. Journal of Hematology & Oncology. 15(1). 83–83. 393 indexed citations breakdown →

Mirzaei, Sepideh, Kiavash Hushmandi, Amirhossein Zabolian, et al.. (2021). Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules. 26(8). 2382–2382. 98 indexed citations

Mirzaei, Sepideh, Ali Zarrabi, Farid Hashemi, et al.. (2021). Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants. 10(3). 349–349. 90 indexed citations

Paskeh, Mahshid Deldar Abad, Maliheh Entezari, Amirhossein Zabolian, et al.. (2021). Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(3). 166326–166326. 51 indexed citations

Mirzaei, Sepideh, Mohammad Gholami, Amirhossein Zabolian, et al.. (2021). Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacological Research. 171. 105759–105759. 138 indexed citations

Paskeh, Mahshid Deldar Abad, Mohammad Gholami, Amirhossein Zabolian, et al.. (2021). EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects. Biomedicine & Pharmacotherapy. 146. 112532–112532. 41 indexed citations

Ashrafizadeh, Milad, Ali Zarrabi, Sima Orouei, et al.. (2021). Interplay between SOX9 transcription factor and microRNAs in cancer. International Journal of Biological Macromolecules. 183. 681–694. 50 indexed citations

Saleki, Hossein, et al.. (2021). Hypericin induces apoptosis in K562 cells via downregulation of Myc and Mdm2. Journal of Cancer Research and Therapeutics. 17(1). 242–247. 7 indexed citations

10.

Mirzaei, Sepideh, Ali Zarrabi, Farid Hashemi, et al.. (2021). Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?. Cancer Letters. 509. 63–80. 186 indexed citations

11.

Paskeh, Mahshid Deldar Abad, Amirhossein Zabolian, Hossein Saleki, et al.. (2021). Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies. International Journal of Molecular Sciences. 22(21). 11669–11669. 34 indexed citations

12.

Paskeh, Mahshid Deldar Abad, Sepideh Mirzaei, Sima Orouei, et al.. (2021). Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence. International Journal of Biological Macromolecules. 191. 727–737. 47 indexed citations

13.

Ashrafizadeh, Milad, Masoud Delfi, Farid Hashemi, et al.. (2021). Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydrate Polymers. 260. 117809–117809. 132 indexed citations

14.

Hashemi, Farid, Ali Zarrabi, Amirhossein Zabolian, et al.. (2021). Novel Strategy in Breast Cancer Therapy: Revealing The Bright Side of Ginsenosides. Current Molecular Pharmacology. 14(6). 1093–1111. 14 indexed citations

15.

Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics. 12(11). 1084–1084. 97 indexed citations

16.

Moghadam, Ebrahim Rahmani, Hui Li Ang, Amirhossein Zabolian, et al.. (2020). Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules. 10(10). 1374–1374. 63 indexed citations

17.

Ashrafizadeh, Milad, Masoud Najafi, Sima Orouei, et al.. (2020). Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines. 8(8). 261–261. 48 indexed citations

18.

Ashrafizadeh, Milad, Masoud Najafi, Hui Li Ang, et al.. (2020). PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines. 8(8). 264–264. 62 indexed citations

19.

Ashrafizadeh, Milad, Saeed Samarghandian, Kiavash Hushmandi, et al.. (2020). Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review. Current Molecular Pharmacology. 14(4). 537–558. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact